tirzepatide po FDA Grants a New Indication for Obesity Management Compounding pharmacies can resume making
Description
Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that works by reducing appetite through dual GIP and GLP-1 receptor activation
Some people tolerate GLP-1-only stimulation from semaglutide much better than the dual agonist approach
By signaling to the brains appetite control center, the hypothalamus, it helps reduce hunger and food cravings, allowing individuals to consume fewer calories naturally
Both medications work best as part of a long-term weight-management plan
